茵陈四物汤加味治疗气血亏虚、湿热瘀阻型冠心病室性期前收缩的临床探究.pdf

提 要 目的：研究茵陈四物汤加味治疗气血亏虚、湿热瘀阻型冠心病室性期前收缩的理 论与临床价值。方法：临床研究中将 60 例冠心病室性期前收缩患者随机分为试验组 30 例，予茵陈四物汤加味治疗；对照组 30 例，予参松养心胶囊口服，4 周为一疗程。 结果：1、茵陈四物汤加味组治疗冠心病性室性期前收缩总有效率为 86.67％，对照组 为 76.67 ％，试验组与对照组比较无显著差异（P ＞0.05 ）。2 、茵陈四物汤加味组中医 症状改善总有效率为 90 ％，对照组 60 ％，试验组与对照组比较有显著性差异（P ＜ 0.05 ）。3、试验组与对照组比较，茵陈四物汤加味组在改善心功能和心电图，降低心 率方面均有较好的疗效。结论：本研究丰富了中医药治疗冠心病室性期前收缩的理论 内容，肯定了茵陈四物汤加味的临床疗效，为进一步深入研究奠定了基础。 关键词 茵陈四物汤加味；室性期前收缩；临床观察 The clinical study of Yinchensiwujiawei decoction to treat the Syndrome of asthenia of Qi and Blood and of impeding of damp and hot and congestion of Premature ventricular beats caused by Coronary heart disease Speciality：Department of Chinese internal medicine Writer ：Yangyonghui Tutor：Professor Zhangshiliang Abstract Objective ： To study the clinical value and theory root of Yinchensiwujiawei decoction to treat the Syndrome of asthenia of Qi and Blood and of impeding of damp and hot and congestion of Premature ventricular beats caused by Coronary heart disease.Methods ： 60 patients of Ventricular premature beat (VPB) caused by Coronary heart disease were randomly divided into the curative group (30 cases) and the control group (30 cases).Shensongyangxin capsule was given to the control group. The other group was dosed Yinchensiwujiawei decoction.The course of clinical treatment is four weeks.Results ： 1. the total effect rate of the curative group of 86.67%,which was not obviously change comparing with the control group of 76.67%(P ＞0.05).2.The total effect rate of ameliorating symptom of the curative group was 90%,which was evidently superior of that of the control group of 60%(P＜0.05).3.The both group had remarkable effect upon improving cardiac functions and electroca